WESTBROOK, Maine, Feb. 11 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. , announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program. Repurchases may be made in the open market (including through Rule 10b5-1 plans) or in negotiated transactions. These shares are in addition to the 2,293,561 shares remaining as of December 31, 2009, under a previous Board authorization. The timing and amount of any repurchases will be at the discretion of the Company’s management.
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,800 people and offers products to customers in over 100 countries.
IDEXX Laboratories, Inc.
